id author title date pages extension mime words sentences flesch summary cache txt cord-300517-41pr3dwa Zhang, Dan The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence 2020-05-05 .txt text/plain 4771 220 32 As recommended in the Guideline on Diagnosis and Treatment of Coronavirus Disease 2019 (Revised 7th version) which was officially released by National Health Commission of the People's Republic of China, TCM could exert favorable effects for patients with different syndromes and distinct stages of COVID-19, contributing to infections in the periods of both medical observation and clinical treatment [23] . In addition, prevenient Chinese research pointed out its clinical J o u r n a l P r e -p r o o f advantages that were related to improve respiratory symptoms, inhibit concurrent bacterial infection, and regulate immune function, superior clinical safety, especially certain hepatoprotective effects, suggesting it might have potentials to relieve some drug-induced liver injury during the treatment of COVID-19 for serious cases [60] . ./cache/cord-300517-41pr3dwa.txt ./txt/cord-300517-41pr3dwa.txt